Pain Management MIPS Tracking for Opioid Measure Report...
Your pain practice manages opioid therapy every day. Your pain management MIPS score rarely shows it. Many clinics still...
Opening Hours: 8:30 A.M. to 8:30 P.M.
You start a patient on a biologic, order the TB test, record a DAS28, and still watch your rheumatology MIPS score miss the mark. The care is sound. The data trail is not. Missing quality data codes (QDCs), uncounted telehealth visits, and a Medicare Part B penalty of up to 9% turn good medicine into lost revenue.
This guide shows which measures capture biologic safety and disease control, how to document them, and which reporting path fits your practice.
MIPS blends four performance categories into one final score out of 100. Rheumatologists need 75 points to avoid a negative Medicare Part B payment adjustment, and the steepest cut is 9%.
Quality 30%, cost 30%, promoting interoperability 25%, improvement activities 15%. Traditional MIPS needs six quality measures, one an outcome or high-priority measure.
Each measure needs data on at least 75% of eligible patients. Below that line, a measure earns zero points in practices above 15 clinicians. Small practices keep three.
Clinicians above all three Medicare thresholds ($90,000 allowed charges, 200 patients, 200 services) must report. The QPP participation lookup confirms status.
MIPS has no single biologic-response measure. Rheumatologists assemble biologic outcomes from four process measures and a set of registry measures.
| Quality ID | Tracks | Counts only when | Key codes |
| 176 | TB screening before a newly started biologic or JAK inhibitor | A TB test falls within 12 months before the prescription | G2182, M1003, M1004, M1005 |
| 177 | RA disease activity | A calculated CDAI, DAS28, PAS-II, RAPID3, or SDAI score at 50% or more of outpatient RA visits | M1007, M1008, M1006 |
| 178 | RA functional status | PROMIS PF10a, HAQ-II, or MD-HAQ completed once in the year | 1170F |
| 180 | Glucocorticoid management | Dose assessed; documented plan when prednisone exceeds 5 mg for over six months with stable or improved disease | 4192F, G2112, G2113, 0540F |
| ACR10, ACR12, ACR14, ACR15, UREQA10 | Hepatitis B screening, PsA activity, serum urate target, hydroxychloroquine dosing, ankylosing spondylitis control | QCDR-reported | Registry-defined |
Quality IDs 176, 177, 178, and 180 are process measures with no high-priority flag. Plan for that gap before you lock your measure set.
Record each result in a structured EHR field dated to the encounter. Registries map structured data elements to measures, and free-text notes risk dropping out.
Both routes are valid, and a practice can submit both. The Advancing Rheumatology Patient Care MVP (MVP ID G0053) asks for four quality measures and one improvement activity, against six measures in traditional MIPS.
One of the four measures must be an outcome or high-priority measure. Quality IDs 176, 177, 178, and 180 do not qualify. Add Quality ID 130 (Documentation of Current Medications), which CMS flags as high priority, or a registry measure designated as an outcome.
CMS has proposed ending traditional MIPS after two more performance years and replacing the outcome or high-priority rule with core measures. The final rule is pending. Our ophthalmology MVP transition guide shows the audit steps.
These three categories carry 70% of the final score. Perfect quality results contribute only 30 points, and 75 is the threshold.
Needs certified EHR technology and a continuous 90-day period. A “No” on Security Risk Analysis, which now adds a risk management attestation, or on the SAFER Guides self-assessment zeroes the category. Optional TEFCA public health reporting adds bonus points.
Needs a continuous 90-day period inside the calendar year. The last practical start date falls in early October. CMS removed eight activities, added three, and replaced the Achieving Health Equity subcategory with Advancing Health and Wellness. Recheck every saved activity.
CMS calculates the Rheumatoid Arthritis episode-based cost measure from Medicare Parts A, B, and D claims, plus Total Per Capita Cost when attribution applies. You submit nothing. Part D drug claims feed the episode; prescribing choices can influence the result.
Points disappear in the data layer, not the exam room. A result that cannot map to a measure counts against your numerator.
After CMS releases final scores, compare your score and adjustment factor with how payments post on your Medicare remittance advice. A mismatch can justify a targeted review under 42 CFR 414.1385. The window closes 30 days after payment adjustments are released. Our guide to billing errors that hurt quality scores covers common coding slips.
Build one documented workflow, review it monthly, and submit through a registry that supports your chosen path. A steady plan beats a December scramble.
This guide showed how rheumatology practices convert biologic safety checks and disease-control tracking into countable MIPS data. It covered the key measures, documentation fixes, the MVP route, and the three categories that decide the final score. QPP MIPS helps eligible clinicians select measures, reconcile denominators, submit accurately, and review results against payment adjustments. Our team handles the reporting workload, freeing clinicians for patient care.
Talk with a MIPS specialist about measure selection, data checks, and the right reporting path for your practice.
Book a Consultation
Are there MIPS measures for lupus?
Yes. The ACR introduced three lupus quality measures that practices can report through MIPS. Confirm availability and specifications with your registry before selecting them.
Is the RISE registry required?
No. Any approved registry, QCDR, or EHR vendor that supports your chosen measures works. RISE adds ACR-built measures and specialty benchmarking.
Do commercial-insurance patients count toward MIPS CQMs?
Yes. MIPS CQMs use all-payer data. Every eligible patient counts, not only Medicare beneficiaries.
Where do I find my final score and payment adjustment?
Sign in to the QPP website with your HARP credentials after CMS releases results. The targeted review tool sits in the same left-hand navigation.
Can anyone guarantee a positive payment adjustment?
No. Positive adjustments carry a scaling factor for budget neutrality, and final scores depend on submitted data. Treat any guarantee as a warning sign.
This article is educational and doesn’t replace legal, billing, or clinical advice. Scores and payment adjustments depend on submitted data and final CMS decisions. No result is guaranteed.
